Center
for Drug Evaluation &
Research (CDER) News |
Center
for Biologics Evaluation &
Research (CBER) |
Center
for Device &
Radiological
Health (CDRH) |
Federal Register -
Meetings, Notices, & Rule Changes |
September 26, 2008
-
Guidance for Industry:
Individual Product
Bioequivalence Recommendations
19 Newly added Bioequivalents.
-
Drugs Shortages: Drugs to be
Discontinued: SecreFlo (porcine
secretin for injection, 16
mcg/vial)
-
Drugs Shortages: Resolved Drugs
Shortages: Zanosar (Streptozocin)
1gm/vial Injection
-
FDA
has been made aware of
preliminary safety findings from
a clinical trial conducted in
Germany investigating the use of
epoetin alfa to treat acute
ischemic stroke.
MedWatch Safety Information
-
New
and Generic Drug Approvals
-
Betamethasone Dipropionate
Topical Cream, Glenmark
Generics, Approval
-
Didanosine
Delayed-Release Capsules,
Aurobindo Pharma, Approval
-
Heparin Sodium
Injection, APP
Pharmaceuticals, LLC,
Labeling Revision
-
Lariam
(mefloquine hydrochloride)
Tablets, Hoffmann-La Roche,
Labeling Revision
-
Nabumetone
Tablets, Dr. Reddy's
Laboratories, Ltd., Approval
-
Noroxin
(norfloxacin) Tablets, Merck
& Co. Inc., Labeling
Revision
-
Symmetrel
(amantadine hydrochloride)
Syrup, Endo Pharmaceuticals,
Labeling Revision
-
Symmetrel
(amantadine hydrochloride)
Tablets, Endo
Pharmaceuticals, Labeling
Revision
-
Office of Generic Drugs:
List of Authorized Generic Drugs
(updated)
-
Transition from
Chlorofluorocarbon (CFC)
Propelled Albuterol Inhalers to
Hydrofluroalkane (HFA) Propelled
Albuterol Inhalers
(podcast)
-
Warning and Untitled Letters
-
Adderall XR Capsules
(Warning Letter)
-
Concerta (methylphenidate
HCl)
-
Diovan (valsartan) Tablets
-
Focalin XR (dexmethylphenidate)
-
Methylin (methylphenidate
HCl)
-
Strattera (atomoxetine HCl)
(Warning Letter)
September 25, 2008
-
FDA
orders companies to stop
marketing unapproved drug
products that contain papain in
a topical dosage form.
Questions and Answers
(updated)
-
Guidance for Industry:
End-of-Phase 2A Meetings [PDF]
or [HTML]
-
International Conference on
Harmonization (ICH) Public
Meeting, October 21, 2008,
Rockville, Maryland:
Meeting information and
registration - (updated)
-
New
and Generic Drug Approvals
-
Amlodipine Besylate
Tablets, Torrent
Pharmaceuticals, Ltd.,
Approval
-
Carboplatin
I.V. Injection, Sun
Pharmaceutical Industries,
Ltd., Approval
-
Nasacort AQ
(triamcinolone acetonide)
Nasal Spray, Sanofi-Aventis
US, LLC, Patient Population
Altered
-
RETROVIR
(zidovudine) Capsules,
GlaxoSmithKline, New Dosage
Regimen
-
RETROVIR
(zidovudine) Syrup,
GlaxoSmithKline, New Dosage
Regimen
-
RETROVIR
(zidovudine) Tablets,
GlaxoSmithKline, New Dosage
Regimen
-
Tarceva
(erlotinib hydrochloride)
Tablets, OSI
Pharmaceuticals, Inc., New
Dosage Regimen
-
Technetium Tc 99m Sestamibi
(technettium tc-99m
sestamibi kit) Injection,
Mallinckrodt Inc., Approval
-
Ventavis
(iloprost) Inhalation
Solution, Actelion, Ltd.,
Labeling Revision
September 24, 2008
September 23, 2008
September 22, 2008
-
FDA
orders companies to stop
marketing unapproved drug
products that contain papain in
a topical dosage form.
Questions and Answers
-
FDA
orders companies to stop
marketing unapproved ophthalmic
balanced salt solutions (BSS). Questions
and Answers
CDER Drug Links
|
Hot Topics
CBER Links
|
| September 26, 2008 |
 |
Federal Register: Medical Devices; Availability of Safety and Effectiveness Summaries for Premarket Approval Applications   |
 |
Summary Information for: NexGen LPS-Flex Mobile Bearing and LPS-Mobile Bearing Knees  |
| |
| September 24, 2008 |
 |
Federal Register: Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; MedWatch: Food and Drug Administration Medical Products Reporting Program   |
 |
FDA Public Health Notification: Radiofrequency Ablation of Lung Tumors - Clarification of Regulatory Status  |
| |
| September 22, 2008 |
 |
Guidance for Industry and FDA Review Staff - Intravascular Administration Sets Premarket Notification Submissions [510(k)]   |
 |
PMA Final Decisions for August 2008  |
| |
|
|
|
|
|
|
|
Medical Device Links
|
|
This
Week
Rule Changes:
NONE |
|
Friday,
Sept. 26, 2008 |
|
NOTICES
Draft Guidance for Industry
on End-of-Phase 2A Meetings;
Availability,
55851–55852 [E8–22669]
[TEXT] [PDF]
Medical Devices:
Availability of Safety and
Effectiveness Summaries for
Premarket Approval
Applications,
55852–55853 [E8–22668]
[TEXT] [PDF]
|
|
Thursday,
Sept. 25, 2008 |
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
55516–55517 [E8–22636]
[TEXT] [PDF]
|
|
Wed.,
Sept. 24, 2008 |
|
NOTICES
Agency Information
Collection Activities;
Proposals, Submissions, and
Approvals,
55108–55111 [E8–22435]
[TEXT] [PDF]
55111–55114 [E8–22440]
[TEXT] [PDF]
Meetings:
Endocrinologic and Metabolic
Drugs Advisory Committee,
55114–55115 [E8–22437]
[TEXT] [PDF]
Product Tracing Systems for
Fresh Produce,
55115–55122 [E8–22430]
[TEXT] [PDF]
|
|
Tuesday,
Sept. 23, 2008 |
|
NOTICES
Enforcement Action Dates:
Ophthalmic Balanced Salt
Solutions for Ocular
Surgical Procedures,
54829–54831 [E8–22305]
[TEXT] [PDF]
Topical Drug Products
Containing Papain,
54831–54834 [E8–22300]
[TEXT] [PDF]
|
|
Monday,
Sept. 22, 2008 |
|
NOTICES
Global Harmonization Task
Force, Study Groups 1 and 5;
Proposed and Final
Documents; Availability;
Correction,
54600 [E8–22094]
[TEXT] [PDF]
|
|
|
|
.jpg)
.gif)


EU - US - ICH GMP
Combination Product
handbook |
|
US GMP Training Booklet |
|
Std. GMPs
- Parts 11, 210, 211, 820 &
ICH Q7 |
|
Med. Device - 11, 50,
54, 56, 807, 812, 814, 820,
510k/PMA |
|
Clinical GCP - Parts 11,
50, 54, 56, 312, 314 & ICH
E2A & E6 |
|
Multi-US GMPs 11, 58,
210/211, 600, 601, 610
& 820 |
|
Parts 210/211 - Drug
GMPs |
|
>210/211
with Part 11 |
|
>210/211
with Part 820 |
|
>210/211
with Parts 820 & 11 |
|
>210/211
w/ Keyword Index |
Part 820
Quality Systems Regs
|
|
Part 58 - GLP Good
Lab. Practice |
Part 11
- Electronic Records w/
Scope and Applications
|
GLP 2 11 & 58 - Part 11
& 58
|
PDMA 11,
203 & 205 - Prescription
Drug Marketing
|
|
|
11
& 820 Electronic Record
and Quality Systems
|
|
|
|
The e-Newsletter of
What's New with CDER, CDRH & CBER
Distributed by the worlds
leader in Federal Regulations,
GMP Publications, Inc. & FDA.COM
Tel: 866-GXPNews (or 856-810-7331) Fax: 856-810-7339
http://www.gmppublications.com /
http://www.fda.com
John Cuspilich, Sr. Editor, GXPNews
If you would
like to advertise in this eNewsletter, call
856-810-1825
|